Supplemental material
Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Open access
2,951
Views
3
CrossRef citations to date
0
Altmetric
Review
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
Eddie Underwooda Novavax, Inc, Gaithersburg, MD, USACorrespondence[email protected]
View further author information
, View further author information
Lisa M. Dunklea Novavax, Inc, Gaithersburg, MD, USAView further author information
, Shabir A. Madhib South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Cynthia L. Gayc Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USAView further author information
, Paul T. Heathd Vaccine Institute, St George’s, University of London and St George’s University Hospitals NHS; Foundation Trust, London, UKView further author information
, Karen L. Kotloffe Paediatric infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland, MD, USAView further author information
, Katherine Smitha Novavax, Inc, Gaithersburg, MD, USAView further author information
, Gordon Chaua Novavax, Inc, Gaithersburg, MD, USAView further author information
, Shirley Galbiatia Novavax, Inc, Gaithersburg, MD, USAView further author information
, Alice McGarrya Novavax, Inc, Gaithersburg, MD, USAView further author information
, Wayne Wooa Novavax, Inc, Gaithersburg, MD, USAView further author information
, Iksung Choa Novavax, Inc, Gaithersburg, MD, USAView further author information
, Katia Alvesa Novavax, Inc, Gaithersburg, MD, USAView further author information
, Germán Áñeza Novavax, Inc, Gaithersburg, MD, USAView further author information
, Chijioke Bennetta Novavax, Inc, Gaithersburg, MD, USAView further author information
, Vivek Shindea Novavax, Inc, Gaithersburg, MD, USAView further author information
, Louis Friesa Novavax, Inc, Gaithersburg, MD, USAView further author information
, Raburn M. Mallorya Novavax, Inc, Gaithersburg, MD, USAView further author information
, Gregory M. Glenna Novavax, Inc, Gaithersburg, MD, USAView further author information
& Seth Tobacka Novavax, Inc, Gaithersburg, MD, USAView further author information
show all
Pages 501-517
|
Received 19 Jan 2023, Accepted 24 May 2023, Published online: 05 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.